Home/Filings/4/0000950170-24-075213
4//SEC Filing

Ji Henry 4

Accession 0000950170-24-075213

CIK 0001820190other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 9:26 PM ET

Size

11.2 KB

Accession

0000950170-24-075213

Insider Transaction Report

Form 4
Period: 2024-06-18
Ji Henry
DirectorCEO and President
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-18$1.41/sh+6,000$8,460311,273 total
  • Exercise/Conversion

    Nonstatutory Stock Option (right to buy)

    2024-06-186,000194,000 total
    Exercise: $1.41Exp: 2033-10-04Common Stock (6,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    292,264
  • Common Stock

    (indirect: By Spouse)
    5,640
  • Common Stock

    (indirect: By BioVintage, Inc.)
    2,749
  • Common Stock

    (indirect: By BioVintage, Inc.)
    50,070
Footnotes (4)
  • [F1]1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
  • [F2]On December 30, 2022, the Board of Directors of Sorrento Therapeutics, Inc. ("Sorrento") declared a stock dividend (the "Dividend") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of Common Stock for each one share of common stock, par value $0.0001 per share, of Sorrento ("Sorrento Common Stock"). The Reporting Person wrote a put option in Sorrento Common Stock on August 26, 2022 (the "Put Option"), which was adjusted as a result of the Stock Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,749 shares of Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Common Stock.
  • [F3](Continued from footnote 2) The Put Option settled on March 17, 2023 and resulted in the Reporting Person becoming entitled to receive 2,749 shares of Common Stock at a price of $8.6002 per share of Common Stock, upon the expiration of the lock-up on such shares which is currently set to expire on September 30, 2024.
  • [F4]Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Documents

1 file

Issuer

Scilex Holding Co

CIK 0001820190

Entity typeother

Related Parties

1
  • filerCIK 0001470981

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:26 PM ET
Size
11.2 KB